Draw
|
Currency :
Home Products

AG003619

943319-70-8 | 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide

943319-70-8
AG003619
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 943319-70-8
Catalog Number AG003619
Chemical Name 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide
IUPAC Name 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
InChI InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)
InChI Key PHXJVRSECIGDHY-UHFFFAOYSA-N
MDL Number MFCD17215203
Molecular Formula C29H27F3N6O
Molecular Weight 532.5595
SMILES O=C(NC2=CC=C(CN3CCN(C)CC3)C(C(F)(F)F)=C2)C1=CC=C(C)C(C#CC5=CN=C4C=CC=NN45)=C1
UNII 4340891KFS
Synonyms
3-(2-(imidazo(1,2-b)pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-y-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide, AP 24534, AP-24534, AP24534, Iclusig, ponatinib, ponatinib hydrochloride, PONATINIB, 943319-70-8, Ponatinib (AP24534), AP24534, AP 24534, Iclusig, 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide, AP-24534, UNII-4340891KFS, AP24534(Ponatinib), CHEMBL1171837, CHEBI:78543, 4340891KFS, 3-(Imidazo[1,2-B]pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)methyl]-3-(Trifluoromethyl)phenyl}benzamide, C29H27F3N6O, 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide, Ponatinib [USAN:INN], ponatinibum, Ponatinb, HSDB 8184, 0LI, 3-(2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide, 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide, AP24534,Ponatinib, Ponatinib (USAN/INN), AP24534 - Ponatinib, QCR-6, MLS006010166, SCHEMBL589260, GTPL5890, CTK5H6398, DTXSID50241426, EX-A067, SYN1116, PHXJVRSECIGDHY-UHFFFAOYSA-N, BCPP000397, HMS3654H16, AOB87302, BCP02037, ABP000881, BDBM50322535, MFCD17215203, ZINC36701290, AKOS015995214, AM81261, BCP9000307, CS-0204, DB08901, PB34916, RL05926, AP-24534, Ponatinib, AP24534, NCGC00263152-01, NCGC00263152-02, NCGC00263152-14, AC-26973, AK172051, AS-19133, BC659935, Benzamide, 3-(2-imidazo(1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methyl-1- piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-, HY-12047, SC-53014, SMR004701274, AB0008178, RT-011294, FT-0660376, S1490, SW218091-2, X4747, KS-00000772, A10080, D09950, Q-4579, AB01565847_03, BRD-K44227013-001-02-3, 3-(2-(Imidazo(1,2-b)pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1- yl)methyl)-3-(trifluoromethyl)phenyl)benzamide, 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-benzamide, BENZAMIDE, 3-(2-IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-[4-[(4-METHYL-1-PIPERAZINYL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL]-, Ponatinib HCl, Ponatinib hydrochloride, Iclusig (TN), Ponatinib [USAN], AP24534Ponatinib, D0H0EQ, cc-191, Tyrosine Kinase Inhibitor - Ns, Ponatinib, 99% - 10MG 10mg, C29-H27-F3-N6-O, ACN-034454, A5467, C545373, 3-(2-(imidazo(1,2-b)pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-y-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide, Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl],

Product Recommendations

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited